Novartis Neoral Labeling Must Drop "Microemulsion" Descriptor, FDA Says
Executive Summary
Novartis Neoral cyclosporine "for microemulsion" is not a unique dosage form, FDA maintained in its Nov. 2 response denying citizen petitions submitted to the agency by the company seeking to block approval of a generic version of Neoral.